Haywood-Small Sarah
Biomolecular Sciences Research Centre, Sheffield Hallam University, City Campus, Howard Street, Sheffield, S1 1WB, UK.
Methods Mol Biol. 2017;1618:1-6. doi: 10.1007/978-1-4939-7051-3_1.
Personalized medicine is gaining momentum and analytical methods such as MS are ideally situated to provide coherent imaging of human disease. The cancer research field is already starting to benefit from the MS imaging applications; non-cancerous diseases will hopefully enjoy the same success. Often, the way forward is to embrace several techniques, which can complement and verify each other. This approach can be seen as less confrontational as everyone can play a part in the development of a new working practice. Stakeholders, professional bodies, and instrument manufacturers will be open to maximizing the patient benefit; investment is more likely given the past performance and reputation of the collaborative highly skilled team.With this in mind, how close are we to a future amalgamation between the scientist and the clinician? Can we accelerate the integration of innovative bench technologies into the clinical setting and bring state-of-the-art imaging diagnostics to the patient bedside or General Practitioners treatment room?
个性化医疗正在蓬勃发展，质谱（MS）等分析方法非常适合用于提供人类疾病的连贯成像。癌症研究领域已经开始从质谱成像应用中受益；非癌症疾病有望取得同样的成功。通常，前进的道路是采用多种技术，这些技术可以相互补充和验证。这种方法可以被视为不那么具有对抗性，因为每个人都可以在新工作实践的发展中发挥作用。利益相关者、专业机构和仪器制造商将乐于最大限度地提高患者受益；鉴于合作的高技能团队过去的表现和声誉，投资更有可能实现。考虑到这一点，我们距离科学家和临床医生未来的融合还有多远？我们能否加速将创新的实验室技术整合到临床环境中，并将最先进的成像诊断技术带到患者床边或全科医生的治疗室？
